Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sanjivani Paranteral is a publicly traded Indian pharmaceutical company that specializes in the development, manufacturing, and export of generic medicines. The company's core expertise lies in parenteral (injectable) formulations and oral solid dosages, produced in WHO-GMP certified facilities located in Navi Mumbai and Dehradun. Their extensive product portfolio covers critical therapeutic areas such as anti-infectives, analgesics, and cardiovascular health. Sanjivani serves as a strategic contract manufacturing partner for global pharmaceutical companies and maintains a significant presence in emerging markets across Africa and Asia. The company is committed to providing high-quality, affordable healthcare solutions through continuous process improvement and international regulatory compliance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sanjivani Pharma.